Education
About Us
Working with TipRanks
Follow Us
Sedana Medical AB (SE:SEDANA)
:SEDANA
Inhaled Isoflurane Administered By Sedaconda Acd-S, Intravenous Infusion Of Propofol
Sedation, Post-Intensive Care Syndrome
Phase III
Active Not Recruiting
A Pooled Analysis of Long-Term Outcomes After Inhaled Isoflurane Via the Sedaconda ACD-S Compared to Intravenous Propofol
Jan 08, 2025
―
Midazolam, Isoflurane
Sedation
Phase III
Completed
Effect & Safety of Inhaled Isoflurane vs IV Midazolam for Sedation in Mechanically Ventilated Children 3-17 Years Old
Dec 18, 2020
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Sedana Medical AB (SEDANA) have in its pipeline
SEDANA is currently developing the following drugs: Inhaled Isoflurane Administered By Sedaconda Acd-S, Intravenous Infusion Of Propofol, Midazolam, Isoflurane. These drug candidates are in various stages of clinical development as the company works toward FDA approval.